Calcium
Also called: calcium carbonate, calcium citrate
Calcium is the most abundant mineral in the body and makes up much of the structure of bones and teeth. Milk, yogurt and cheese are rich sources. Supplements most often supply calcium carbonate or calcium citrate; labels declare elemental calcium.
- Category
- Mineral
- Forms
- Calcium carbonate; calcium citrate (labels state elemental calcium)
- Strongest evidence
- B Some positive trials
- Reviewed
- 2026-10-28
Class 1 Well studied in people. NIH ODS describes a 2018 Cochrane review of 27 RCTs of calcium supplements in pregnancy (18,064 women); in the 13 high-dose trials (15,730 women), none gave vitamin D. [1]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels2 topics
BPregnancy and infants1 topic
CBones and joints1 topic
XBlood sugar and weight1 topic
XCancer1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Bone density and fractures in older adults | C | Meta-analyses were mixed: calcium with vitamin D raised bone density, but a review of 14 RCTs found calcium alone did not lower hip fracture; USPSTF found no fracture benefit from under 1,000 mg calcium with under 400 IU vitamin D daily in postmenopausal women. [1] |
| Blood pressure in adults | B | A Cochrane review (16 trials, 3,048 adults, 1,000–2,000 mg/day) reported systolic blood pressure 1.43 mmHg and diastolic 0.98 mmHg lower than control. [1] |
| Preeclampsia in pregnancy | B | A Cochrane review (27 RCTs, 18,064 women) reported fewer cases with at least 1,000 mg/day, mainly in women with low calcium intake; evidence quality was low and large trials were not significant. [1] |
| Overall cancer risk | X | A meta-analysis of 10 RCTs (10,496 people, at least 500 mg/day, mean 3.9 years) found no change in total cancer risk; a 4-year RCT (2,303 women, 1,500 mg plus vitamin D) also found none. [1] |
| Cardiovascular disease | C | A 2021 meta-analysis of 13 double-blind, placebo-controlled trials reported a 15% higher risk of cardiovascular disease with calcium supplements (RR 1.15, 95% CI 1.06 to 1.25), specifically in healthy postmenopausal women; other analyses have reached different conclusions, so the question remains unsettled. [5] |
| Body weight and body fat | X | A meta-analysis of 41 RCTs (4,802 adults) found calcium supplements had no effect on weight or body fat. [1] |
Main constituents: Calcium carbonate (about 40% elemental calcium by weight) [1]; Calcium citrate (about 21% elemental calcium) [1]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Adult RDA: 1,000 mg/day ages 19–50 (including pregnancy and lactation) and men 51–70; 1,200 mg/day women 51–70 and all adults over 70. [1]
- Fracture meta-analysis (8 RCTs, 30,970 adults over 50): 500–1,200 mg calcium plus 400–800 IU vitamin D daily for 1–7 years. [1]
- Women's Health Initiative: 1,000 mg calcium carbonate plus 400 IU vitamin D3 daily. [1]
- ACOG and WHO recommend 1,500–2,000 mg/day for pregnant women with low dietary calcium. [1]
- Absorption is highest at doses of 500 mg or less (about 36% at 300 mg vs. 28% at 1,000 mg). [1]
Upper limits
- Adult UL: 2,500 mg/day ages 19–50 (including pregnancy and lactation); 2,000 mg/day ages 51 and older. The ULs are based on Women's Health Initiative data linking 1,000 mg/day supplemental calcium to kidney stones. [1]
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingNIH ODS: the Tolerable Upper Intake Level for calcium is 2,500 mg/day for ages 19–50, including pregnancy and lactation …
1 statement in the profile.
Details and sources - Interactions with medicines4 listed
Quinolone antibiotics; Levothyroxine; Lithium; Dolutegravir
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications5 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Kidney stones: the ULs rest on a link between supplemental calcium and kidney stones in the Women's Health Initiative; two later reviews found no such association. [1]
- Hypercalcemia (serum above 10.5 mg/dL) is rare in healthy people and is usually caused by cancer or primary hyperparathyroidism; symptoms include renal insufficiency, constipation, nausea, fatigue and arrhythmias. [1]
- High intakes may increase cardiovascular disease and prostate cancer risk, though not all studies agree. [1]
- Calcium carbonate causes more gas, bloating and constipation than calcium citrate, especially in older adults. [1]
Interactions
| With | What happens |
|---|---|
| Dolutegravir | Calcium can substantially reduce dolutegravir blood levels; take dolutegravir 2 hours before or 6 hours after calcium. [1] |
| Levothyroxine | Calcium carbonate can reduce absorption; avoid taking levothyroxine within 4 hours of the supplement. [1] |
| Lithium | Long-term lithium use can cause hypercalcemia, and combined use with calcium may increase that risk. [1] |
| Quinolone antibiotics (ciprofloxacin, gemifloxacin, moxifloxacin) | Calcium reduces absorption; take the antibiotic 2 hours before or 2 hours after calcium. [1] |
| Iron | Calcium may reduce absorption of both nonheme and heme iron, though this is not definitively established; experts suggest taking calcium and iron supplements at different times of day. [2] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
Regulatory status
- US: sold as a dietary supplement ingredient. FDA Daily Value: 1,300 mg for adults and children age 4 and older. [1]
- Authorized health claim (21 CFR 101.72, calcium, vitamin D, and osteoporosis). Model wording: "Adequate calcium throughout life, as part of a well-balanced diet, may reduce the risk of osteoporosis." [3]
- FDA qualified health claim letters of enforcement discretion (October 12, 2005): "Calcium and Colon/Rectal Cancer and Calcium and Colon/Rectal Polyps" and "Calcium and Hypertension, Pregnancy-Induced Hypertension, and Preeclampsia". [4]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
- Calcium carbonate (40% calcium by weight) and calcium citrate (21% calcium); other supplement forms include calcium sulfate, ascorbate, microcrystalline hydroxyapatite, gluconate, lactate and phosphate Mineral (calcium salts) [P5]
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 5 entries naming calcium carbonate (earliest NDI 347 submitted 2005-09-09; most recent NDI 594 submitted 2009-06-17). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. Other entries name calcium only as part of a different ingredient (for example, calcium salts of L-5-methyltetrahydrofolate) or name other calcium compounds (for example, calcium formate). [P1]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
- No IARC evaluation of calcium or the calcium salts used in supplements (calcium carbonate, calcium citrate) was found (IARC Monographs list of classifications checked 2026-10-29). [P3]
- No NTP technical report on calcium or the calcium salts used in supplements (calcium carbonate, calcium citrate) was found (NTP technical reports list checked 2026-10-29). [P4]
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Quinolone antibiotics: NIH ODS: calcium can reduce absorption of quinolone antibiotics; ODS states this effect is avoided by taking the antibiotic 2 hours before or 2 hours after calcium supplements. [P5]
- Levothyroxine: NIH ODS: calcium carbonate can interfere with levothyroxine absorption; the levothyroxine label advises avoiding it within 4 hours of taking the supplement. [P5]
- Lithium: NIH ODS: long-term lithium can cause hypercalcemia, and use of both lithium and calcium supplements could increase this risk. [P5]
- Dolutegravir: NIH ODS: dolutegravir should be taken 2 hours before or 6 hours after calcium supplements. [P5]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- No published information found in the sources checked.
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of the dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants a petition for an exemption under 111.75(a)(1)(ii). [P2]
- Lead (heavy metal) assay — Ross et al. (JAMA 2000) measured lead in 4 of 7 natural (oyster shell) and 4 of 14 refined calcium carbonate supplements, including some brand-name products not of oyster shell origin, and concluded that many calcium supplement formulations contain lead. [P6]
Supply and conservation
- Calcium carbonate supplements include natural (oyster shell) and refined formulations (Ross et al., JAMA 2000). [P6]
Absorption in people
- NIH ODS: absorption from supplements is highest with doses of 500 mg or less; the body absorbs about 36% of a 300 mg calcium dose and 28% of a 1,000 mg dose. [P5]
- NIH ODS: low stomach acid reduces calcium carbonate absorption unless it is taken with a meal; calcium citrate is less dependent on stomach acid for absorption. Net dietary calcium absorption is as high as 60% in infants and young children and falls to about 25% in adulthood. [P5]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- NIH ODS: the Tolerable Upper Intake Level for calcium is 2,500 mg/day for ages 19–50, including pregnancy and lactation; the RDA in pregnancy and lactation is 1,000 mg (ages 19–50) and 1,300 mg (ages 14–18). [P5]
Sources for this profile
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- IARC Monographs. List of Classifications (checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program. Technical Reports (list checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- NIH Office of Dietary Supplements. Calcium: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-27), 2026-10-27. ods.od.nih.gov
- Ross EA, Szabo NJ, Tebbett IR. Lead content of calcium supplements. JAMA 2000;284(11):1425-9 (PMID 10989406), 2000-09-20. pubmed.ncbi.nlm.nih.gov
Sources
- NIH Office of Dietary Supplements. Calcium: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-27), 2026-10-27. ods.od.nih.gov
- NIH Office of Dietary Supplements. Iron: Fact Sheet for Health Professionals (updated 2025-09-04), 2025-09-04. ods.od.nih.gov
- eCFR. 21 CFR 101.72 Health claims: calcium, vitamin D, and osteoporosis (up to date as of 10/08/2026), 2026-10-08. ecfr.gov
- US Food and Drug Administration. Qualified Health Claims: Letters of Enforcement Discretion (content current as of 03/28/2024), 2024-03-28. fda.gov
- Myung SK, et al. Calcium supplements and risk of cardiovascular disease: a meta-analysis of clinical trials. Nutrients 2021;13(2):368 (PMID 33530332), 2021-01-26. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in mineral: Boron · Chromium · Copper · Iodine · Iron · Magnesium · Manganese · Molybdenum · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.